impedimed.com valid

Automatically discovered from public files. Ownership management is optional. Inclusion does not imply endorsement or publisher participation.

Manage this listing — optional · Visit publisher ↗

Claim my listing on Agent Web Map for impedimed.com:
1. POST https://agentwebmap.com/v1/sites/impedimed.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://impedimed.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/impedimed.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/impedimed.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verify

Corrections or removal requests: contact the directory. Ownership management is optional.

ImpediMed

Generated by All in One SEO Pro v5.0.3, this is an llms.txt file, used by LLMs to index the site.

Their llms.txt

The beginning of the file, from our validated copy saved 2026-10-21T15:12:18.454Z. Cached copy · Source on impedimed.com

# ImpediMed

> Generated by All in One SEO Pro v5.0.3, this is an llms.txt file, used by LLMs to index the site.

## Sitemaps

- [XML Sitemap](https://www.impedimed.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [The Time is Now: Prospective Surveillance and the New Standards](https://www.impedimed.com/the-time-is-now-prospective-surveillance-and-the-new-standards/): Learn now one prospective surveillance model can align your breast cancer center to three new 2027 NAPBC standards in this free webinar with Dr. Nicole Stout.
- [SOZO Assembly](https://www.impedimed.com/sozo-assembly/)
- [L-Dex Bilateral Report](https://www.impedimed.com/l-dex-bilateral-report/): Explore the L-Dex bilateral report, offering a thorough analysis of both limbs for a comprehensive approach to lymphedema monitoring.
- [L-Dex Unilateral Report](https://www.impedimed.com/l-dex-unilateral-report/): Examine the L-Dex unilateral report, providing targeted insights for assessing lymphedema in a single limb, enhancing personalized patient care.
- [Muscle Over Weight: What Every Cancer Patient Should Know About the New Era of Weight-Loss Medicine](https://www.impedimed.com/muscle-over-weight-what-every-cancer-patient-should-know-about-the-new-era-of-weight-loss-medicine/): GLP-1 weight-loss drugs can cost cancer patients up to 40% of their loss in muscle, not fat. Learn why preserving lean muscle is now central to cancer care.
- [Bioimpedance Spectroscopy (BIS) at the Intersection of Whole-Body Care](https://www.impedimed.com/bioimpedance-spectroscopy-bis-at-the-intersection-of-whole-body-care/): Learn how bioimpedance spectroscopy and body composition assessment can strengthen lymphedema surveillance and NAPBC alignment in this webinar.
- [Building Strength & Recovery for Athletic Performance: Using bioimpedance spectroscopy (BIS) to assess fluid balance in Sports Medicine for optimal sport performance and recovery](https://www.impedimed.com/building-strength-and-recovery-for-athletic-performance/): Learn how Bioimpedance Spectroscopy (BIS) informs athlete recovery, hydration, and return-to-play decisions in sports medicine in this free webinar.
- [Maureen McBeth on GLP-1s, Muscle Loss and Bioelectrical Impedance Spectroscopy (BIS)](https://www.impedimed.com/maureen-mcbeth-on-glp-1s-and-bis/): Maureen McBeth discusses GLP-1-related muscle loss, the importance of body composition monitoring, and how BIS technology can support better patient outcomes.
- [Richelle Gaw, PhD](https://www.impedimed.com/richelle-gaw/): Richelle Gaw, PhD, is Director of Research Science & Medical Affairs at ImpediMed, leading bioimpedance spectroscopy research and clinical validation.
- [Scott Long](https://www.impedimed.com/scott-long/): Meet Scott Long, SVP of US Sales, Key Accounts, and Renewals at ImpediMed, with 30+ years of sales leadership in the breast cancer device market.
- [Erik Johnson](https://www.impedimed.com/erik-johnson/): ImpediMed’s steady growth
…

Related sites

Other listed sites in Marketing. See the whole category →

Help agents understand your site

Optionally manage your description, publish terms for agents, review file health, measured discovery requests, publisher clicks and score history. Confirm domain control in your browser using a fresh token in your llms.txt, DNS, meta tag or well-known file. No backlink is required.

Manage this listing → · Agent and API instructions

Machine-readable: GET /v1/resolve?q=impedimed.com · GET /v1/domain/impedimed.com · this page as Accept: application/json or text/markdown · MCP lookup_domain